CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1 by Fujita Ken-ichi, Yamamoto Wataru, Endo Shoji, Endo Hisashi, Nagashima Fumio, Ichikawa Wataru, Tanaka Ryuhei, Miya Toshimichi, Araki Kazuhiro, Kodama Keiji, Sunakawa Yu, Narabayashi Masaru, Miwa Keisuke, Ando Yuichi, Akiyama Yuko, Kawara Kaori, Kamataki Tetsuya, Sasaki Yasutsuna in Cancer science (2008).

[PMID: 18380793] PubMed

Abstract

Discussed In Paper

Loading...

Variant Annotations

Sign in to see variant annotations.

Dosing Information

No dosing information annotated.